Atlas Trials

A Phase II Study in Patients With Alopecia Areata

Clinical trial NCT04346316 · COMPLETED

Trial details

NCT number
NCT04346316
Sponsor
Reistone Biopharma Company Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2020-05-13
Primary completion
2021-06-10
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.